 Intravenous thrombolysis has become a standard practice in eligible patients with acute ischemic stroke (AIS). Functional outcome after AIS is a major concern for patients, families, and neurologists. Identifying factors affecting the early functional outcome and the effect of IV rTPA in Egyptian AIS patients is crucial to address concerns and queries.